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ABSTRACT Dynamic light scattering and Fourier transform infrared spectroscopy were used to study the formation of preﬁbrillar
aggregates and ﬁbrils of bovine pancreatic insulin at 60C and at pH 1. The kinetics of disintegration of the preﬁbrillar aggregates
were also studied using these techniques after a quench to 25C. These experiments reveal that formation of preﬁbrillar
aggregates is reversible under the solution conditions studied and show that it is possible to signiﬁcantly reduce the nucleation
(lag) times associated with the onset of ﬁbril growth in bovine pancreatic insulin solutions by increasing the concentration of
preﬁbrillar aggregates in solution. These results provide convincing evidence that less structured preﬁbrillar aggregates can act as
ﬁbril-forming intermediates.
INTRODUCTION
Amyloid ﬁbril formation is increasingly being considered to
be a property of all globular proteins (1). A recent article by
Chiti and Dobson has cited 40 different human diseases that
have been linked with the formation of these amyloid protein
deposits (2). However, ﬁbrils are not the only type of protein
aggregate that have been associated with these conditions. A
number of recent studies have also reported the existence of
smaller aggregates that precede ﬁbril formation (3–9). The
importance of understanding the processes that are involved
in the formation of the aggregates that precede ﬁbril forma-
tion (preﬁbrillar aggregates) has been highlighted because of
evidence that they (and not mature ﬁbrils) may be the main
cytotoxic species (6,8–11). It has been suggested that it is the
misfolded nature of the proteins that leads to the cytotoxicity
of these aggregates (8). Misfolded globular proteins often
have exposed hydrophobic residues that are usually hidden in
the core of the molecules. The exposure of these residues
could be responsible for abnormal interactions between the
protein molecules and the constituents of a cell. As a result,
the biochemical reactions that take place in and around the
cell may be hindered by the presence of these aggregates (2).
However, recent work by Yoshiike et al. (12) has challenged
these ideas. These authors propose that the lack of correlation
that has been reported between the quantity of ﬁbrils and their
measured toxicity could be caused by variations in the
physicochemical properties of different ﬁbril morphologies.
Smith et al. studied insulin ﬁbril formation and showed
that small aggregates with an average radius of ;13 nm
formed before the ﬁbrils (13). The insulin molecules that
made up these preﬁbrillar aggregates were found to adopt a
conformation containing a small amount of intermolecular
b-sheet structure. Ahmad et al. (7) have also provided experi-
mental evidence for the existence of preﬁbrillar aggregates at
several lower protein concentrations than those studied by
Smith and co-workers. These studies indicate that preﬁbrillar
aggregates are found under a variety of solution conditions
that are capable of initiating ﬁbril formation.
A key question that arises from these studies is related to
whether preﬁbrillar aggregates are a necessary precursor for
the nucleation of ﬁbrils, or whether they simply represent a
competing aggregation pathway. Studies have been pub-
lished that indicate that both of these scenarios can occur
(4,5,14–16). The task of elucidating the relationship between
preﬁbrillar aggregates and protein ﬁbril nucleation therefore
continues to be of considerable importance.
In this article, we describe an experimental study of the
formation of preﬁbrillar aggregates and ﬁbrils in solutions of
bovine pancreatic insulin (BPI) at elevated temperature and at
pH 1. A combination of Fourier transform infrared (FTIR)
spectroscopy and dynamic light scattering (DLS) measure-
ments were used to study the formation of these aggregates at
60C. These techniques were also used to study the disinte-
gration of preﬁbrillar aggregates after a rapid temperature
quench from 60C to 25C. We show that it is possible to
vary the concentration of preﬁbrillar aggregates in solution
by varying the time after the quench. We also show that the
nucleation (lag) time associated with the formation of ﬁbrils
depends upon the concentration of preﬁbrillar aggregates in
solution. These experiments provide convincing evidence
that the presence of nonﬁbrillar aggregates in solution can
reduce the ﬁbril nucleation (lag) times and promote the onset
of insulin ﬁbril formation.
METHODS
Protein sample preparation
Stock solutions containing 0.025 M NaCl and 0.1 M HCl (pH 1) were pre-
pared in preboiled deuterium oxide (D2O; Goss Scientiﬁc Instruments,
Chelmsford, Essex, UK). These solutions were sealed in 15 mL sample vials
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and degassed by placing them in a temperature-controlled water bath at 85C
for ;1 h. The solutions were then allowed to cool to room temperature.
Bovine pancreatic insulin (BPI;Mw ¼ 5733, cat. No. I5500, Sigma Aldrich,
Gillingham, Dorset, UK) was dissolved in the stock solutions at a concen-
tration of 20 mg mL1 (;3.5 mM). The resulting protein solutions were left
at room temperature in sealed vials for a further 24 h to ensure that all the
protein had dissolved.
After the protein had dissolved, the sealed sample vials were heated to
60C on a THMS600 hot-stage (Linkam Scientiﬁc Instruments, Tadworth,
Surrey, UK) using a homebuilt heater assembly. The vials were held at this
temperature for 1 h. This procedure has been shown to result in the formation
of preﬁbrillar aggregates in the protein solutions, but no insulin ﬁbrils are
formed on these timescales (13). The samples were then quenched rapidly to
25C by placing them in a temperature-controlled water bath.
The protein solutions were then separated into two sets (A and B, re-
spectively) and each sample set was subjected to a different thermal history.
Sample set A was reheated to 60C immediately (within 5 min) after the
quench and was maintained at this temperature to allow the aggregation/ﬁbril
formation of the protein to reach completion. Sample set B was maintained at
a temperature of 25C for 120 h after the quench. This protein solution was
then heated to 60C and allowed to undergo further aggregation and ﬁbril
formation. In each case, the samples were held at 60C for at least 150 min
after being reheated. Previous work has shown that this is the length of time
required for the aggregation of BPI to reach completion at this temperature
and under this set of solution conditions (13).
In all the experiments described below, duplicate measurements were
carried out. Additional experiments could not be performed, as all the ex-
periments were carried out using a single batch of insulin. This was done
because signiﬁcant batch-to-batch variations in the properties of insulin have
been reported (13,17). The use of a single batch of BPI therefore ensures that
any observed changes in the kinetics of aggregation of the samples are en-
tirely due to differences in the way the samples are treated and not due to the
batch dependent properties of the protein.
Dynamic light scattering
Small aliquots of BPI solution were taken from sample B at different times
after the temperature quench from 60C to 25C. These aliquots were rapidly
transferred to a quartz cuvette and DLS measurements were performed using
a Viscotek (Crowthorne, Berkshire, UK) DLS apparatus (laser wavelength
633 nm). Before collection of the experimental data, the DLS equipment was
calibrated against a series of polystyrene colloid standards of different sizes
(46 nm, 98 nm, and 306 nm). The temperature was maintained at 25C
throughout the experiments and the size distributions of the aggregates and
the total scattered light intensity were recorded as a function of time. Data
were initially collected at 5-min intervals for a period of 2 h. Following this,
data were collected at 1 h intervals for a further 21 h.
Fourier transform infrared spectroscopy
Aliquots of solutions taken from sample B were also injected into an FTIR
liquid transmission cell (75-mm pathlength; Specac, Orpington, Kent, UK)
after the temperature quench. The temperature of the cell was maintained at
25C and infrared spectra were collected every 5 min (averaging 250 scans
per spectrum, 4 cm1 resolution) for a period of 30 h using an FTS40 Pro
spectrometer (Varian, Oxford, UK) equipped with Resolutions Pro 4.0
software (Varian, Oxford, UK). All the spectra collected were ratioed to a
background spectrum (averaging 250 scans per spectra) of the sample so-
lution that did not contain BPI.
FTIR spectra were also collected from samples A and B and used to
follow the aggregation process by monitoring changes in the b-sheet content
of the BPI solutions when the samples were reheated to 60C. During these
experiments, infrared spectra were collected at 15-s intervals for a period of
150 min. All spectra were collected using a resolution of 4 cm1.
RESULTS AND DISCUSSION
Fig. 1 shows size distributions obtained from DLS mea-
surements of the BPI solutions that were collected at different
times after a temperature quench from 60C to 25C. All the
data shown in this ﬁgure is normalized so that the intensity of
the peak corresponding to the largest particle size observed is
equal to one. This allows a qualitative comparison of the
relative concentrations of each aggregate type to be made at
each time. Fig. 1 shows that shortly after the quench, the BPI
solutions contain a signiﬁcant number of aggregates with an
average radius of ;13 nm as well as a small number of
structures that have a radius of ;2–4 nm. This ﬁgure also
shows that the distribution of sizes of the larger (;13 nm)
aggregates varies between 7 nm and 30 nm. The smaller (2–4
nm) structures are similar in size to those observed when
insulin is dissolved at 25C under the solution conditions
used in this study (pH 1, 0.025 M NaCl). They are compa-
rable to structures reported in other studies of insulin and are
likely to arise as a result of the formation of insulin dimers
and larger oligomeric structures that are known to occur
under these solution conditions (7,18).
The larger (13 nm) preﬁbrillar aggregates were observed to
disintegrate into the;2–4 nm aggregates after the quench to
25C. This can be observed in Fig. 1 by the increase in the
relative size of the peak corresponding to the 2–4 nm ag-
gregates. It is worth noting that none of the DLS size distri-
butions collected during these experiments revealed the
presence of any aggregates of intermediate or larger sizes.
The upper limit of the length scales that can be measured
using DLS is ;1 mm. Aggregates that are $1 mm in size
would be clearly visible in solution. No structures of this size
were observed in the solutions containing the preﬁbrillar
aggregates. However, when the solutions were incubated at
60C for extended periods and ﬁbrils were allowed to form,
FIGURE 1 Particle size distributions obtained from DLS studies of
preﬁbrillar aggregates in solutions of BPI (20 mg mL1, pH 1) after a
temperature quench from 60C to 25C. Data were collected at times of 150
min (dotted line), 500 min (dashed line), and 2940 min (solid line) after the
quench. All size distributions are normalized in such a way that the size of
the peak centered at ;13 nm is equal to unity.
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the solutions were observed to go cloudy. These observations
are consistent with reports obtained in a previous study in
which insulin ﬁbrils were formed under similar solution
conditions (13).
A more detailed inspection of the size distributions shown
in Fig. 1 reveals that there is some evidence for a narrowing in
the distributions of the larger (;13 nm) aggregate sizes as
they disintegrate. It is not clear whether the narrowing is
related to some property of the size-dependent disintegration
kinetics of the aggregates or it is simply an artifact of the
assumptions that are made about the geometry of the aggre-
gates when calculating the size distributions (see below).
Determining the reasons for the narrowing of the distribution
of sizes with increasing disintegration times would be difﬁ-
cult without a more detailed (real or reciprocal space) anal-
ysis of the size distributions of the aggregates using a number
of different experimental techniques. Such an analysis is
beyond the scope of this study.
The kinetics of preﬁbrillar aggregate disintegration can be
followed more clearly by monitoring the total intensity of
light scattered from all the objects in solution as a function of
time (5). Fig. 2 shows the time-dependent decay in the total
scattering intensity measured in the DLS experiments after a
quench from 60C to 25C. This ﬁgure shows that as time
proceeds and the larger aggregates disintegrate into smaller
structures, the total scattering intensity decreases. These
measurements also indicate that the decay in scattering
intensity and hence the dissociation of the preﬁbrillar ag-
gregates takes place on timescales in excess of 40 h.
The observed decay in the scattering intensity can be inter-
preted using basic Rayleigh scattering theory. If we assume that
to a ﬁrst approximation, all the scattering objects in solution can
be treated as spheres, the scattering intensitywould be expected
to scale as ;cR6 (where R and c are the radius and concen-
trations of the aggregates, respectively) (19). During the dis-
integration of the larger aggregates, the concentration of






: As a result, the scattering intensity from a pop-
ulation comprised entirely of smaller aggregates (Is) would be
related to the intensity from a population of the larger aggre-
gates (Il) by the equation







where Rs and Rl are the radii of the small and large aggre-
gates, respectively. Equation 1 conﬁrms that the total scat-
tering intensity is expected to decrease as the larger
aggregates disintegrate into the smaller aggregate structures.
The assumption that the aggregates are spherical is likely
to be a poor one. Evidence for this was obtained by using an
Asylum Research MFP 3D atomic force microscope (AFM,
operating in tapping mode) to collect images of dried solu-
tions that contain clusters of preﬁbrillar aggregates. As
shown in the inset of Fig. 2, the larger aggregates are not
spherical objects. There is some indication that the preﬁ-
brillar aggregates are relatively compact but that they have a
slightly elongated structure. This will modify the interpreta-
tion of the light scattering intensity data shown in Fig. 2,
because a change in the geometry of the scattering objects
will introduce a different size dependence into the scattering
intensity. However, the qualitative behavior of the size de-
pendence of the scattering intensity would be expected to be
the same (i.e., a decrease in scattering intensity with de-
creasing object size). It is also worth noting that the DLS
software used to determine the size of the aggregates in so-
lution makes the assumption that the scattering objects are
spherical. As discussed above, this assumption may not be
valid for the larger aggregates and great care must be taken
when interpreting the DLS size distributions shown in Fig. 1.
As a result, the value of ;13 nm represents an average
measure of the hydrodynamic radius of the larger aggregates.
A more detailed examination of the AFM image shown in
the inset of Fig. 2 shows that the lateral sizes of the structures
observed are signiﬁcantly larger than the ;13 nm radius
aggregates detected in the DLS measurements. The reason
for this is that the image shown in the inset of Fig. 2 was
obtained from a sample that was prepared by drying the BPI
solutions on a clean polystyrene-coated, single crystal silicon
wafer. During drying of the solutions, the aggregates cluster
together under the inﬂuence of surface tension at the receding
edge and surface of the drying droplet. Care must therefore be
taken when interpreting AFM images such as the one shown
in the inset of Fig. 2. AFM images of dried samples can only
be used to obtain a qualitative comparison of the aggregate
morphologies that exist in a given sample (13). However, it is
worth noting that AFM line scans taken across the aggregate
clusters shown in the image in Fig. 2 reveal that the height of
these objects is 8 6 1 nm. This value is comparable to the
FIGURE 2 Light scattering and FTIR studies of the disintegration of
preﬁbrillar aggregates in solutions of BPI (20 mg mL1, pH 1) after a
temperature quench from 60C to 25C. Data are shown for the decay in the
total light scattering intensity (n, DLS) and the area of the ratioed b-sheet
peak (s, FTIR, see text) as a function of time. The inset shows an AFM
image of clusters of preﬁbrillar aggregates taken over a 5 mm 3 5 mm area.
The scale bar on this image corresponds to a distance of 1 mm.
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;13-nm average hydrodynamic radius of the aggregates that
was obtained from the DLS measurements.
The disintegration of the preﬁbrillar aggregates was also
studied using FTIR spectroscopy. This technique enables
changes in the secondary structure of the protein that are
associated with the state of aggregation to be monitored as a
function of time (13). Fig. 3 shows FTIR spectra of the BPI
solutions taken at times of 5, 60, 150, 500, and 2100 min after
the quench from 60C to 25C. This ﬁgure shows that as the
preﬁbrillar aggregates disintegrate, there is also a consider-
able change in the shape of the Amide I region of the IR
spectrum of insulin. As discussed in a previous publication
(13), this region can be accurately ﬁtted to three Lorentzian
peaks which correspond to vibrational frequencies associated
with random coil (;1645 cm1), a-helix (;1658 cm1), and
b-sheet structures (;1610–1633 cm1), respectively. Fitting
Lorentzian line shapes to these peaks enables the relative
content of these structures within the protein molecules to be
determined (13). Fig. 3 shows that there is a gradual decrease
in the size of the b-sheet shoulder (;1620 cm1) of the
amide I region of the protein spectra with time, after the
quench to 25C. Qualitatively, this suggests that the b-sheet
content of the protein molecules that comprise the ;13-nm
aggregates decreases as the aggregates disintegrate.
A more detailed analysis of the relative areas of the peaks
corresponding to the different secondary structures (a-helix,
b-sheet, and random coil) was performed on the protein
molecules in the BPI solutions. Table 1 gives a summary of
the relative proportions of the different secondary structures
obtained from the IR spectra of the disintegrating aggregates
of BPI shown in Fig. 3. The relative proportions of the dif-
ferent secondary structures obtained from a freshly dissolved
BPI solution are also shown in this table for comparison. As
shown in Table 1, the ratio of (b-sheet:a-helix/random coil)
in the protein varied from 32%:33%:35% (immediately after
the quench to 25C) to 10%:53%:37% after ;35 h. These
values conﬁrm that the disintegration of the larger preﬁbrillar
aggregates is accompanied by signiﬁcant changes in the
secondary structure of the protein. These changes are con-
sistent with other reports of differences in the secondary
structure of preﬁbrillar aggregates and freshly dissolved in-
sulin that were collected under similar solution conditions
(13,20,21).
The peak ﬁtting procedure employed here (and described
in detail elsewhere (13)) was used to determine the variation
in the b-sheet content of the protein as a function of time (see
Fig. 2). The area of the b-sheet peak plotted in Fig. 2 has been
divided by the total area of the amide I region. The total area
of the amide I region contains information about all of the
secondary structures that exist within the protein molecules
in solution and hence provides a quantitative measure of the
amount of protein in the beam path. Dividing the area of the
b-sheet peak by the total area of the amide I peak in this way
therefore provides a measure of the amount of b-sheet per
unit volume in the samples being studied (13).
Fig. 2 shows that the kinetics associated with the decrease
in b-sheet content of BPI occur on similar timescales to the
disintegration of the larger aggregates (as determined from
the decrease in light scattering intensity). As the preﬁbrillar
aggregates disintegrate, the shape of the amide I peak (and
hence the relative proportions of the different secondary
structures) appears to revert to a state that is similar to that
observed in freshly dissolved insulin (see Figs. 2 and 3 and
also Table 1). The correspondence between the timescales
associated with the b-sheet content of BPI molecules and the
dissociation of preﬁbrillar aggregates (measured by DLS)
suggests that intermolecular b-sheet plays an important role
in determining the structure of the preﬁbrillar aggregates
reported here (as has been established for the case of protein
ﬁbrils (18)). However, as shown previously, the b-sheet
content per unit volume of the preﬁbrillar aggregates is
smaller than that observed for insulin ﬁbrils (13).
Smith et al. (13) have also shown that preﬁbrillar aggre-
gates of insulin are able to bind Thioﬂavin-T (ThT) dye
molecules in such a way as to produce a signiﬁcant amount of
FIGURE 3 FTIR spectra collected during the disintegration of preﬁbrillar
aggregates in solutions of BPI (20 mg mL1, pH 1) after a temperature
quench from 60C to 25C. Data are shown for spectra collected at times of
5 (s), 60 (h), 150 (n), 500 (d), and 2100 min (n) after the quench. The
solid line is a spectrum taken from freshly dissolved insulin at 25C.
TABLE 1
% Content
Time (min) b-sheet Random coil a-Helix
5 32 6 1 35 6 1 33 6 1
60 28 6 1 38 6 1 34 6 1
150 23 6 1 40 6 1 37 6 1
500 19 6 1 39 6 1 42 6 1
2100 10 6 1 37 6 1 53 6 1
Freshly dissolved 7 6 1 39 6 1 54 6 1
Time dependence of the secondary structure content of BPI solutions after
the quench from 60C to 25C. Data were obtained by calculating the areas
of three Lorentzian line shapes (corresponding to b-sheet, a-helix, and
random coil, respectively) that were ﬁtted to each of the spectra shown in
Fig. 3 (see text).
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ﬂuorescence. The presence of a measurable ThT ﬂuorescence
intensity (above background levels) suggests that these ag-
gregates contain repeat b-sheet units that are aligned in such
a way that the ThT dye molecules can lie across several
b-strands associated with different protein molecules (22).
This indicates that the structures formed by the insulin mole-
cules within these aggregates display some of the character of
molecules that have been incorporated into mature ﬁbrils (7).
The ability to change the concentration of preﬁbrillar ag-
gregates by varying the time after a temperature quench
provides a useful way of assessing their importance for ﬁbril
formation. As described above, samples A and B were held at
25C for different periods of time (5 min and 120 h, re-
spectively) after a quench from 60C. These samples were
then reheated and incubated at 60C to allow ﬁbrils to form in
solution. The differences in preﬁbrillar aggregate concen-
trations between these two solutions were then used to de-
termine how preﬁbrillar aggregates inﬂuence the nucleation
(lag) times associated with ﬁbril formation. During this time,
the b-sheet content of the samples was monitored using FTIR
spectroscopy (see Methods). As shown by Smith et al.,
monitoring the b-sheet content of the protein molecules in
solution provides a valid method of following the aggrega-
tion process in solutions of BPI (13).
Fig. 4 shows the variation of the b-sheet content of BPI
molecules in samples A and B as a function of time. This
ﬁgure also shows the variation in the b-sheet content of BPI
taken from a sample of freshly dissolved protein that was
incubated at 60C for the entire period shown on the plot (i.e.,
with no temperature quench to 25C). All of the plots shown
in Fig. 4 display the characteristic two-phase aggregation
kinetics that have been reported previously for BPI under
these solution conditions (13). The region in the b-sheet
formation kinetics up to the end of the ﬁrst plateau corre-
sponds to changes associated with the formation and satu-
ration of a population of;13-nm preﬁbrillar aggregates. The
region of growth after this plateau has been attributed to
changes in the b-sheet content of the protein associated with
the formation of ﬁbrils (13). The horizontal error bars on the
plots shown in Fig. 4 were determined from repeat mea-
surements of the FTIR b-sheet formation kinetics and are a
measure of the level of experimental uncertainty in the ﬁbril
nucleation (lag) times.
The times associated with the onset of ﬁbril nucleation for
the two samples studied (A and B) are clearly different within
the limits of experimental uncertainty (see Fig. 4). The nu-
cleation time for the sample containing a signiﬁcant popu-
lation of ;13 nm preﬁbrillar aggregates (sample A) is
signiﬁcantly shorter (40 6 19 min) than the nucleation time
observed in the samples where these aggregates have been
partially dissolved by holding the protein solutions at 25C
for 120 h (sample B). These simple experiments indicate that
the difference in time that the samples were kept at 25C (and
hence the size of the population of preﬁbrillar aggregates),
before being reheated, affects ﬁbril nucleation times.
The data shown for sample A in Fig. 4 clearly demon-
strates that the ﬁbril nucleation time is shortened by 526 19
min relative to that observed for a solution of freshly dis-
solved protein incubated at the same temperature. As this
time difference is the same within error as the 60 min that
sample set A was incubated before the quench, these results
indicate that rapidly quenching the protein solutions and then
immediately reheating them preserves most of the population
of the preﬁbrillar aggregates. As a result, the aggregation
continues as if the quench had not occurred. However, when
preﬁbrillar aggregates are allowed to dissociate (as in the case
of sample B), the aggregation history of the system is ef-
fectively erased and the protein returns to a conformation
which is predominantly a-helix and random coil (see Fig. 3).
Whether the BPI molecules return to the same conformation
as freshly dissolved insulin is not certain. However, the con-
formation contains similar proportions of the different
secondary structures to those observed for freshly dissolved
BPI (see Table 1), making this a reasonable assumption.
As mentioned above, the difference in ﬁbril nucleation
times observed between sample sets A and B was found to be
40 6 19 min. It might be expected that if the protein in
sample B had reverted to its native conformation, the dif-
ference in nucleation times would correspond closely to the
FIGURE 4 Fibril nucleation studies in BPI solutions (20 mg mL1, pH 1)
with different thermal histories. Data are shown for the ratioed b-sheet
growth kinetics obtained from FTIR spectroscopy measurements of BPI
solutions (see text). The data were collected from freshly dissolved BPI
solutions that were incubated at 60C (d), as well as solutions that were
heated to 60C for 60 min before being quenched to 25C and then reheated
to 60C within 5 min (n) and held at 25C for 120 h before being reheated to
60C (s). The solid lines shown in this ﬁgure mark the position of the
plateau corresponding to the end of preﬁbrillar aggregate formation and the
slopes of the regions corresponding to the period of ﬁbril growth (13),
respectively. The nucleation (lag) times for ﬁbril growth can be determined
from the times at which the ﬁbril growth slopes intersect the plateau line.
The horizontal error bars represent the uncertainty in the ﬁbril nucleation
times obtained in each set of experiments and are shown on a single data
point in each set for reasons of clarity.
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60 min of heating that each sample experienced before the
FTIR transmission measurements (as observed for freshly
dissolved insulin). However, while the difference in the nu-
cleation times between sample sets A and B is comparable to
60 min (within the limits of experimental uncertainty), it
should be noted that it is unlikely that the preﬁbrillar aggre-
gates in sample set B would have completely dissociated,
even after 120 h.
An alternative interpretation of the results shown in Fig. 4
could be given in terms of the differences in concentrations
of the smaller protein structures (i.e., insulin monomers and
dimers) that exist between the two samples. However, this is
unlikely to be the dominant factor in affecting the ﬁbril nu-
cleation times. We would expect that decreasing the con-
centrations of these structures would reduce the probability
of them interacting in solution. If these structures were di-
rectly responsible for nucleating ﬁbrils, this reduction in the
collision probability would result in a longer ﬁbril nucleation
time being observed in the solutions with the lower con-
centrations of these smaller protein structures (i.e., in sample
A). This is not observed in the experiments reported here.
A consideration of Fig. 4 shows that once preﬁbrillar ag-
gregates have formed, a further;80 min is required for ﬁbril
nucleation to take place. This can be deduced from the length
of the plateau region observed in the ﬁrst stage of the b-sheet
formation kinetics shown for freshly dissolved insulin in
Fig. 4. If preﬁbrillar aggregates are responsible for nucleus
formation, as these experiments suggest, then why don’t
ﬁbrils nucleate immediately after these aggregates have
formed, and what processes are occurring during the period
corresponding to the plateau region in the kinetics?
Closer inspection of the plateau in the FTIR b-sheet ki-
netics in Fig. 4 reveals that the plateau is not completely ﬂat,
but exhibits a slight increase throughout the time preceding
ﬁbril nucleation. These changes indicate that the physical
environment of the b-strands of the BPI molecules within the
preﬁbrillar aggregates is changing during this time. This
suggests that some local rearrangement of the BPI molecules
may be taking place within the aggregates and that some BPI
molecules reorganize into conformations that are more con-
ducive to ﬁbril formation.
A number of previous experimental studies have also
shown that less well-deﬁned aggregates form before ﬁbrils in
other protein systems. These studies have shown that struc-
tural rearrangements of the protein molecules can take place
within the preﬁbrillar aggregates and that these structural
changes typically occur on timescales.;10 h (2,4,5,10,14).
For example, Petty et al. performed studies of the Syrian
hamster prion peptide (H1) and used isotope-modiﬁed IR
spectroscopy to show that before ﬁbril growth there is a
necessary reorganization and alignment of b-strands within
preﬁbrillar aggregates (10). They showed that the rearrange-
ment and alignment of the b-strands in these aggregates dis-
played an Arrhenius temperature dependence and that the
structural changes lead to ﬁbril nucleus formation. These
combined results suggest that the time taken for realignment
of b-strands within the preﬁbrillar aggregates is likely to be
the rate-limiting step for ﬁbril nucleation in the current
studies and may explain the associated lag time after the
saturation of the population of preﬁbrillar aggregates.
In summary, our results suggest that the preﬁbrillar ag-
gregates formed in this study cause the insulin molecules to
cluster together in relatively compact and slightly elongated
structures. Our experiments indicate that preﬁbrillar aggre-
gation involves the formation of some intermolecular b-sheet
between the insulin molecules, but that the b-sheet content
per unit volume of these aggregates is initially smaller than
that of mature ﬁbrils. However, the formation of preﬁbrillar
aggregates does not appear to quench in the structure of the
protein molecules, as there is some evidence of changes in
the b-sheet content of the protein during the plateau region of
the FTIR b-sheet kinetics and before the onset of ﬁbril for-
mation. This suggests that there is some annealing of the
intermolecular b-sheet structure within these aggregates (see
Fig. 4) and that the protein molecules have some freedom to
sample different conformational states.
The experimental observation that preﬁbrillar aggregates
reduce the ﬁbril nucleation (lag) times provides strong evi-
dence that these aggregates can play an important role in
initiating ﬁbril formation. One possible explanation for the
reduction in ﬁbril nucleation times could be given in terms of
the high local concentrations of BPI molecules that exist
within the preﬁbrillar aggregates. The radius of gyration of
isolated insulin molecules under the solution conditions used
in this study is;1.6 nm (23). If we assume that the molecules
are closely packed within the;13-nm preﬁbrillar aggregates,
then each aggregate would contain ;500 molecules (de-
pending on its size and shape). The localization of the protein
molecules in these aggregates would be expected to increase
the frequency associated with two given BPI molecules in-
teracting and adopting the conformations required for ﬁbril
formation (when compared to isolated molecules and dimers
in solution). This provides a possible explanation for the
reason why the formation of preﬁbrillar aggregates reduces
the nucleation times associated with ﬁbril formation. How-
ever, we stress that determining the mechanism by which
these aggregates promote the nucleation of ﬁbrils is not
possible without a detailed analysis of the molecular rear-
rangements that take place within the aggregate. Such an
analysis is currently beyond the scope of this work.
CONCLUSIONS
Dynamic light scattering and FTIR spectroscopy were used
to study the formation and disintegration of preﬁbrillar ag-
gregates in solutions of bovine pancreatic insulin (BPI) at
60C and pH 1. Preﬁbrillar aggregates of BPI were found to
have an average radius of ;13 nm and their formation was
shown to be reversible. The protein molecules in the preﬁ-
brillar aggregates contained a greater amount of b-sheet
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content per unit volume than freshly dissolved insulin, but a
lower b-sheet content than ﬁbrils. The concentration of
preﬁbrillar aggregates was shown to depend upon the thermal
history of the samples. Solutions with high concentrations of
preﬁbrillar aggregates were shown to display signiﬁcantly
shorter ﬁbril nucleation (lag) times than freshly dissolved BPI
and solutions containing fewer aggregates. These experi-
ments suggest that preﬁbrillar aggregates act as nucleating
agents for ﬁbrils and that the localization of many (;500)
protein molecules in these aggregates enables the BPI mol-
ecules to undergo the structural rearrangements that are re-
quired for ﬁbrillogenesis.
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